Marktlink → Sectors → Science & Health → Healthcare

  • Updated February 27, 2026

Recurring revenue and specialization drive premiums

Healthcare is the most recession-proof and increasingly competitive M&A sector. PE-backed platforms aggressively consolidate specialty care and home health across Europe. Specialty clinics with multi-location models and digital health companies with recurring SaaS revenue attract premium valuations and multiple bidders. General practices without scale or digital infrastructure face longer processes and smaller buyer pools.

Jeroen van den Berg

Sector Lead Science & Health • 14 years • 90+ transactions

“Healthcare is the most recession-proof sector in our portfolio — and increasingly the most competitive. PE-backed platforms are aggressively consolidating specialty care and home health across Europe. For sellers, the key question is: do you have recurring patient revenue and a scalable model? If yes, you will have multiple bidders. If you are a single-location general practice, the process will be longer and the pool smaller.”

Sector at a Glance

  • Updated March 2, 2026
VALUATION RANGE

0x – 0x

↑ +0.2x vs 2024

EBITDA Multiple
Deals in 2025

0

Active Buyers

0+

Enter your figures → see your position instantly

Valuation Development

Healthcare valuations proved resilient through economic cycles, with specialty and platform models recovering fastest.

5-Year Multiple Range

2021 PEAK

0.0x avg

Peak: COVID resilience premium

2023 DIP

0.0x avg

Correction: rate hikes, labor costs

2025 NOW

0.0x avg

Recovery: PE dry powder deployed

Subsegment Analysis

Specialty Care & Clinics

[XX] deals in 2025

Multiple Range

0.0x – 0.0x

+0.3x
Buyer Mix
PE 40% • Strategic 50%
Key Valuation Driver
Multi-location scale, specialty focus, and ancillary revenue streams
Am I in this segment? →

Home Care & Elderly Services

[XX] deals in 2025

Multiple Range

0x – 0x

+0.2x
Buyer Mix
PE 35% • Strategic 50%
Key Valuation Driver
Recurring care contracts, geographic coverage, and staff retention rates
Am I in this segment? →

Healthcare IT & Digital Health

[XX] deals in 2025

Multiple Range

0.0x – 0x

+0.5x
Buyer Mix
PE 35% • Strategic 50%
Key Valuation Driver
Recurring SaaS revenue, clinical workflow integration, and AI capability
Am I in this segment? →

Primary & General Care

[XX] deals in 2025

Multiple Range

0.0x  – 0x

+0.0x
Buyer Mix
PE 20% • Strategic 60%
Key Valuation Driver
Patient base size, location, and conversion to managed care model
Am I in this segment? →

Buyer Landscape 2025

Overall Buyer Type Distribution

  • What drives premium valuations

Multi-location platform with scalable model

+0.0x to +0.0x

Recurring patient contracts (managed care)

+0.0x to +0.0x

Digital health / AI integration in workflows

+0.0x to +0.0x

Specialty focus with certification barriers

+0.0x to +0.0x

Staff retention above 90% in care delivery

+0.0x to +0.0x

Which of these buyers match your firm?

BuyersChecker analyzes your profile against our active buyer database.

Recent Transactions

Anonymized Marktlink cases showing the platform vs single-location valuation dynamics in healthcare.

Platform Premium

Specialty Care

Multi-location ophthalmology clinic chain with 8 locations across the Netherlands, own surgical center, and growing patient base with strong referral network

REVENUE

€0.0M

EBITDA

€0.0M

MULTIPLE

0.0x

DURATION

0 months

8 locations
Own surgical center
70% insured recurring

Key Insight

The PE buyer valued the multi-location model and own surgical center as a scalable platform for further consolidation. 8 locations across the Netherlands provided geographic coverage that would take years to build organically. Ancillary surgical revenue added 1-2x premium.

Stability Premium

Home Care & Elderly

Regional home care organization providing nursing care, personal care, and domestic support with 350+ employees and long-term municipal contracts across 3 provinces

REVENUE

€0.0M

EBITDA

€0.0M

MULTIPLE

0.0x

DURATION

0 months

350+ employees
80% government contracts
92% staff retention

Key Insight

Government-backed home care contracts provided revenue stability that justified the premium above general care. Staff retention of 92% was a critical metric — in a sector where labor is the product, employee loyalty directly translates to service quality and contract retention.

SaaS Premium

Healthcare IT

Cloud-based patient management and scheduling platform serving 200+ dental and physiotherapy practices across DACH, with strong NPS and 95% annual retention

REVENUE

€0.0M

EBITDA

€0.0M

MULTIPLE

0.0x

DURATION

0 months

90% SaaS recurring
200+ practices
95% retention rate

Key Insight

90% recurring SaaS revenue and 95% retention rate created exceptional buyer demand — 14 parties for a EUR 6M revenue company is remarkable. The buyer valued the clinical workflow integration as a moat: switching costs for practices are extremely high once patient data is in the system.

Succession Pricing

Primary Care

Group of 3 general practice locations in a mid-sized Dutch city, founder-led with strong patient base but limited digital infrastructure and succession pressure

REVENUE

€0.0M

EBITDA

€0.0M

MULTIPLE

0.0x

DURATION

0 months

Founder-dependent
3 locations
Limited digital

Key Insight

Without multi-location scale, digital infrastructure, or specialty focus, the buyer pool was limited. The 11-month process reflects the challenge of selling a founder-dependent general practice. Practices that invest in digital systems and managed care models before selling achieve significantly higher multiples.

Recognize yourself in these cases? Compare your situation.

Market Trends 2025

European healthcare consolidation accelerates

Large European healthcare operators like Mehiläinen and Affidea are consolidating at scale. Companies reaching EUR 200-300M EBITDA are now hardwired for M&A growth, creating a robust exit market for mid-market sellers.

Source: HBI 2025, Rothschild & Co

€0.0B

Mehiläinen CEE acquisitions 2025

PE dry powder drives platform premiums

Private equity holds $1.4 trillion in undeployed capital globally, with healthcare a top deployment target. PE platforms are paying 2-4x premium for platform-size practices above EUR 5M EBITDA versus smaller add-ons.

Source: HBI 2025, FOCUS Bankers 2026

$0.0T

global PE dry powder

AI and digital health command premiums

Profitable HealthTech companies command 10-14x EBITDA multiples in 2025. AI-driven solutions in diagnostics, clinical decision support, and revenue cycle management attract the highest buyer interest.

Source: Nelson Advisors Aug 2025

0–0x

profitable HealthTech EBITDA

Labor scarcity shapes deal economics

Healthcare M&A is dominated by strategic buyers at 86% of deals. Labor scarcity is making workforce stability a key valuation driver — companies with strong staff retention command measurable premiums.

Source: PCE Healthcare Q3 2025

0%

strategic buyers in healthcare M&A

What This Means for You

Interactive tools that give you immediate insights—or full reports in your personal portal.

30 sec

Marktlink Multiple

Your estimated valuation

Direct: Indicative multiple

Portal: Detailed range + comparable deals
+ factors breakdown

Start tool

30 sec

BuyersChecker

How many buyers match you

Direct: Number of matches

Portal: Buyer profiles + alerts when
new buyers match

Start tool

30 sec

Benchmark Tool

Your performance vs sector

Direct: Position indication

Portal: Full benchmark report
+ quarterly updates

Start tool

30 sec

Buyer Appeal Scan

Which buyers want you

Direct: Top buyer type

Portal: All buyer types ranked + appeal factors
+ matching profiles

Start tool

1 min

Timing Scan

Market timing analysis

Direct: Timing score

Portal: Detailed timing report
+ market alerts

Start tool

2 min

Sale Readiness Test

How prepared are you

Direct: Readiness score

Portal: Full assessment
+ personalized action plan

Start tool

Industry Report 2025

Everything on this page, plus: 12 additional deal cases, detailed subsegment analysis, and 2026 outlook.

Follow This Sector

Receive updates when valuations change, new buyers emerge, or relevant deals close.

  • Valuation changes
  • Deal announcements
  • New buyer profiles
  • Quarterly updates